1. Home
  2. LGCB vs GTBP Comparison

LGCB vs GTBP Comparison

Compare LGCB & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • GTBP
  • Stock Information
  • Founded
  • LGCB 2011
  • GTBP 1965
  • Country
  • LGCB Japan
  • GTBP United States
  • Employees
  • LGCB N/A
  • GTBP N/A
  • Industry
  • LGCB
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • GTBP Health Care
  • Exchange
  • LGCB Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • LGCB 6.1M
  • GTBP 5.5M
  • IPO Year
  • LGCB 2023
  • GTBP N/A
  • Fundamental
  • Price
  • LGCB $1.93
  • GTBP $2.23
  • Analyst Decision
  • LGCB
  • GTBP Strong Buy
  • Analyst Count
  • LGCB 0
  • GTBP 1
  • Target Price
  • LGCB N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • LGCB 1.1M
  • GTBP 17.4K
  • Earning Date
  • LGCB 05-27-2025
  • GTBP 05-15-2025
  • Dividend Yield
  • LGCB N/A
  • GTBP N/A
  • EPS Growth
  • LGCB N/A
  • GTBP N/A
  • EPS
  • LGCB N/A
  • GTBP N/A
  • Revenue
  • LGCB $10,289,681.00
  • GTBP N/A
  • Revenue This Year
  • LGCB N/A
  • GTBP N/A
  • Revenue Next Year
  • LGCB N/A
  • GTBP N/A
  • P/E Ratio
  • LGCB N/A
  • GTBP N/A
  • Revenue Growth
  • LGCB N/A
  • GTBP N/A
  • 52 Week Low
  • LGCB $1.22
  • GTBP $1.72
  • 52 Week High
  • LGCB $57.05
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 50.54
  • GTBP 46.01
  • Support Level
  • LGCB $1.88
  • GTBP $2.30
  • Resistance Level
  • LGCB $2.12
  • GTBP $2.37
  • Average True Range (ATR)
  • LGCB 0.14
  • GTBP 0.15
  • MACD
  • LGCB 0.01
  • GTBP -0.01
  • Stochastic Oscillator
  • LGCB 41.43
  • GTBP 14.55

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: